Cargando…
Neoadjuvant chemotherapy in well-differentiated fetal adenocarcinoma: a case report
BACKGROUND: Fetal adenocarcinoma of the lung is a rare subtype of pulmonary adenocarcinoma with a relative estimated incidence of 0.5% or fewer of all lung cancers. Because of its extreme rarity, there have been no controlled clinical trials investigating treatment regimens for fetal adenocarcinoma...
Autores principales: | Lkhoyaali, Sihame, Boutayeb, Saber, Ismaili, Nabil, Aitelhaj, Meriem, Ouchen, Fahd, Benosman, Abdellatif, Errihani, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017811/ https://www.ncbi.nlm.nih.gov/pubmed/24886749 http://dx.doi.org/10.1186/1756-0500-7-283 |
Ejemplares similares
-
First line chemotherapy plus trastuzumab in metastatic breast cancer HER2 positive - Observational institutional study
por: Aitelhaj, Meryem, et al.
Publicado: (2016) -
Les effets bénéfiques de l'accompagnement du patient cancéreux: particularités du Maroc
por: Lkhoyaali, Sihame, et al.
Publicado: (2014) -
La langue noire villeuse: après chimiothérapie
por: Lkhoyaali, Sihame, et al.
Publicado: (2014) -
The burden among family caregivers of elderly cancer patients: prospective study in a Moroccan population
por: Lkhoyaali, Sihame, et al.
Publicado: (2015) -
Triple malignancy in a single patient including a cervical carcinoma, a basal cell carcinoma of the skin and a neuroendocrine carcinoma from an unknown primary site: A case report and review of the literature
por: Mesmoudi, Mohamed, et al.
Publicado: (2011)